Correlation Between Monopar Therapeutics and ENBRIDGE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and ENBRIDGE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and ENBRIDGE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and ENBRIDGE INC 425, you can compare the effects of market volatilities on Monopar Therapeutics and ENBRIDGE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of ENBRIDGE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and ENBRIDGE.

Diversification Opportunities for Monopar Therapeutics and ENBRIDGE

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Monopar and ENBRIDGE is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and ENBRIDGE INC 425 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENBRIDGE INC 425 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with ENBRIDGE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENBRIDGE INC 425 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and ENBRIDGE go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and ENBRIDGE

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 59.58 times more return on investment than ENBRIDGE. However, Monopar Therapeutics is 59.58 times more volatile than ENBRIDGE INC 425. It trades about 0.39 of its potential returns per unit of risk. ENBRIDGE INC 425 is currently generating about 0.06 per unit of risk. If you would invest  2,446  in Monopar Therapeutics on November 9, 2024 and sell it today you would earn a total of  2,265  from holding Monopar Therapeutics or generate 92.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Monopar Therapeutics  vs.  ENBRIDGE INC 425

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
ENBRIDGE INC 425 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ENBRIDGE INC 425 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, ENBRIDGE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Monopar Therapeutics and ENBRIDGE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and ENBRIDGE

The main advantage of trading using opposite Monopar Therapeutics and ENBRIDGE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, ENBRIDGE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENBRIDGE will offset losses from the drop in ENBRIDGE's long position.
The idea behind Monopar Therapeutics and ENBRIDGE INC 425 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation